Skip navigation
Home
Browse
Communities
& Collections
Browse Items by:
Issue Date
Author
Title
Advisor
Help
Sign on to:
My DSpace
Receive email
updates
Edit Profile
Adelaide Research & Scholarship
Adelaide Research & Scholarship
Search
Search:
All collections
University Library
Library Publications
Aurora harvest
Aurora harvest 2
Aurora harvest 3
Aurora harvest 4
Aurora harvest 5
Aurora harvest 6
Aurora harvest 7
Aurora harvest 8
Aurora submissions
Library publications
News / The University of Adelaide Libraries [1993-2001]
NEWSLINE
University of Adelaide Library News [1979-1993]
Untitled
for
Current filters:
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Start a new search
Add filters:
Use filters to refine the search results.
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Results 1-10 of 16 (Search time: 0.004 seconds).
previous
1
2
next
Item hits:
Preview
Issue Date
Title
Author(s)
2014
The relationship between rash, tumour KRAS mutation status and clinical and quality of life outcomes in patients with advanced colorectal cancer treated with cetuximab in the NCIC CTG/AGITG CO.17
Sommeijer, D.
;
Karapetis, C.
;
Zalcberg, J.
;
Tu, D.
;
Jonker, D.
;
Simes, J.
;
Tebbutt, N.
;
Yip, D.
;
Price, T.
;
O'Callaghan, C.
2018
Liver resection for colorectal cancer metastases: a comparison of outcomes over time in South Australia
Sultana, A.
;
Meng, R.
;
Piantadosi, C.
;
Brooke-Smith, M.
;
Chen, J.
;
Dolan, P.
;
Maddern, G.
;
Price, T.
;
Padbury, R.
2015
Does the chemotherapy backbone impact on the efficacy of targeted agents in metastatic colorectal cancer? A systematic review and meta-analysis of the literature
Chan, D.
;
Pavlakis, N.
;
Shapiro, J.
;
Price, T.
;
Karapetis, C.
;
Tebbutt, N.
;
Segelov, E.
;
Rosell, R.
2013
Overview of biomarkers in metastatic colorectal cancer: tumour, blood and patient-related factors
Clarke, S.
;
Karapetis, C.
;
Gibbs, P.
;
Pavlakis, N.
;
Desai, J.
;
Michael, M.
;
Tebbutt, N.
;
Price, T.
;
Tabernero, J.
2012
Impact of age on choice of chemotherapy and outcome in advanced colorectal cancer
Khattak, M.
;
Townsend, A.
;
Beeke, C.
;
Karapetis, C.
;
Luke, C.
;
Padbury, R.
;
Maddern, G.
;
Roder, D.
;
Price, T.
2013
Association of hypomagnesemia with inferior survival in a phase III, randomized study of cetuximab plus best supportive care versus best supportive care alone: NCIC CTG/AGITG CO.17
Vickers, M.
;
Karapetis, C.
;
Tu, D.
;
O'Callaghan, C.
;
Price, T.
;
Tebbutt, N.
;
van Hazel, G.
;
Shapiro, J.
;
Pavlakis, N.
;
Gibbs, P.
;
Blondal, J.
;
Lee, U.
;
Meharchand, J.
;
Burkes, R.
;
Rubin, S.
;
Simes, J.
;
Zalcberg, J.
;
Moore, M.
;
Zhu, L.
;
Jonker, D.
2010
Randomized phase III study of panitumumab with fluorouracil, leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as second-line treatment in patients with metastatic colorectal cancer
Peeters, M.
;
Price, T.
;
Cervantes, A.
;
Sobrero, A.
;
Ducreux, M.
;
Hotko, Y.
;
Andre, T.
;
Chan, E.
;
Lordick, F.
;
Punt, C.
;
Strickland, A.
;
Wilson, G.
;
Ciuleanu, T.
;
Roman, L.
;
Van Cutsem, E.
;
Tzekova, V.
;
Collins, S.
;
Oliner, K.
;
Rong, A.
;
Gansert, J.
2011
Impact of KRAS and BRAF gene mutation status on outcomes from the phase III AGITG MAX Trial of capecitabine alone or in combination with Bevacizumab and Mitomycin in advanced colorectal cancer
Price, T.
;
Hardingham, J.
;
Lee, C.
;
Weickhardt, A.
;
Townsend, A.
;
Wrin, J.
;
Chua, A.
;
Shivasami, A.
;
Cummins, M.
;
Murone, C.
;
Tebbutt, N.
2010
Capecitabine, bevacizumab, and mitomycin in first-line treatment of metastatic colorectal cancer: results of the Australasian gastrointestinal trials group randomized phase III MAX study
Tebbutt, N.
;
Wilson, K.
;
Gebski, V.
;
Cummins, M.
;
Zannino, D.
;
van Hazel, G.
;
Robinson, B.
;
Broad, A.
;
Ganju, V.
;
Ackland, S.
;
Forgeson, G.
;
Cunningham, D.
;
Saunders, M.
;
Stockler, M.
;
Chua, Y.
;
Zalcberg, J.
;
Simes, R.
;
Price, T.
2007
Phase III trial of capecitabine plus oxaliplatin as adjuvant therapy for stage III colon cancer: A planned safety analysis in 1 864 patients
Schmoll, H.
;
Cartwright, T.
;
Tabernero, J.
;
Nowacki, M.
;
Figer, A.
;
Maroun, J.
;
Price, T.
;
Lim, R.
;
Van Custem, E.
;
Park, Y.
;
McKendrick, J.
;
Topham, C.
;
Soler-Gonzalez, G.
;
de Braud, F.
;
Hill, M.
;
Sirzen, F.
;
Haller, D.
Discover
Author
9
Tebbutt, N.
6
Karapetis, C.
5
Pavlakis, N.
3
Peeters, M.
3
Shapiro, J.
3
Tabernero, J.
3
Van Cutsem, E.
3
Zalcberg, J.
2
Cervantes, A.
2
Chan, E.
.
next >
Subject
15
Humans
12
Colorectal Neoplasms
12
Middle Aged
11
Aged
11
Female
11
Male
10
Adult
10
Antineoplastic Combined Chemother...
8
Aged, 80 and over
7
Antibodies, Monoclonal
.
next >
Date issued
15
2010 - 2018
1
2007 - 2009